Insulin aspart, recombinant Subcutaneous and Selzentry (Maraviroc Tablets)
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Selzentry (Maraviroc Tablets) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: maraviroc
Brand name: Selzentry
Synonyms: Selzentry
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Semaglutide
- Insulin aspart, recombinant Subcutaneous-Semaglutide Prefilled Pens
- Insulin aspart, recombinant Subcutaneous-Semaglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Semaglutide Tablets
- Insulin aspart, recombinant Subcutaneous-Semprex-D
- Insulin aspart, recombinant Subcutaneous-Semprex-D Oral
- Selzentry (Maraviroc Tablets)-Insulin degludec
- Selzentry (Maraviroc Tablets)-Insulin Degludec (U-100) Prefilled Pens
- Selzentry (Maraviroc Tablets)-Insulin Degludec (U-100) Vials
- Selzentry (Maraviroc Tablets)-Insulin Degludec (U-200) Prefilled Pens
- Selzentry (Maraviroc Tablets)-Insulin degludec and liraglutide
- Selzentry (Maraviroc Tablets)-Insulin degludec and liraglutide Subcutaneous